CatalystPit

ATOSATOSSA THERAPEUTICS, INC.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $1.95 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$19.46M
CountryUSA
RECENT INSIDER TRADES
  • 2026-05-14 · Remmel H. Lawrence (Director) · OTHER
  • 2026-05-14 · Chen Shu-Chih (Director) · OTHER
  • 2026-05-14 · Cigler Tessa (Director) · OTHER
  • 2026-05-14 · Finn Jonathan (Director) · OTHER
  • 2026-05-14 · Steinhart Richard I (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders41
Shares held16,971,755
Value$17.42M
Percent of shares outstanding170.07%
As of quarter end2026-06-30
RECENT NEWS
  • Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value
  • Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher
  • Atossa Therapeutics CEO to speak on aging disease clinical trials
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ATOSSA THERAPEUTICS, INC. (ATOS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit